Jorgensen became CEO in January 2017 and the company’s market capitalization has more than tripled during his tenure. Novo was first to market with Wegovy and its sister drug Ozempic for diabetes, but ...

Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...

The president’s Middle East visit produced multibillion-dollar technology investments by the Saudis and Emiratis. But they ...

Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

The top reasons weight loss supplements fail and why most solutions don't address both day and night fat-burning cycles; How PhenQ works as a powerful daytime fat burner to help r ...

Meghan Trainor changed a certain lyric in "All About That Bass" during a May 10 performance in Huntington Beach, Calif.

Sophia Umansky—the daughter of Kyle Richards and Mauricio Umansky—doubled down on her decision to take Mounjaro, despite ...

Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...

WeightWatchers, known for its diet programs once endorsed by celebrities including Oprah Winfrey, has filed for bankruptcy after struggling to compete with drugs like Ozempic.

As the 133 members of the College of Cardinals begin the conclave to vote for the next pope, millions will be keeping an eye on the Sistine Chapel’s chimney to see if a consensus has been reached.

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Honeywell ...